Nomura Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Nomura Holdings’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,268	Closed	-$175	–	1643
2018 Q1	$175	Sell	12,268 -46,732	-79%	-$692K	﹤0.01%	1353
2017 Q4	$827K	Hold	59,000	–	–	﹤0.01%	1172
2017 Q3	$842K	Buy	+59,000	New	+$843K	﹤0.01%	1099
2016 Q3	–	Sell	-11,600	Closed	-$226K	–	1434
2016 Q2	$226K	Buy	+11,600	New	+$227K	﹤0.01%	1015
2015 Q4	–	Sell	-11,297	Closed	-$194K	–	2157
2015 Q3	$194K	Sell	11,297 -6,926	-38%	-$127K	﹤0.01%	1424
2015 Q2	$340K	Buy	18,223 +4,110	+29%	+$76.2K	﹤0.01%	1404
2015 Q1	$269K	Sell	14,113 -21,643	-61%	-$400K	﹤0.01%	1390
2014 Q4	$589K	Buy	+35,756	New	+$613K	﹤0.01%	1566
2014 Q3	–	Sell	-10,718	Closed	-$221K	–	3129
2014 Q2	$221K	Buy	+10,718	New	+$220K	﹤0.01%	2322
2014 Q1	–	Sell	-8,558	Closed	-$226K	–	2966
2013 Q4	$226K	Sell	8,558 -8,257	-49%	-$203K	﹤0.01%	1695
2013 Q3	$397K	Buy	+16,815	New	+$393K	﹤0.01%	1524

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nomura Holdings's VIVO Position: Q2 2018 in Review

Nomura Holdings sold out of Meridian Bioscience Inc (VIVO) in Q2 2018, closing a stake of 12,268 shares — an estimated $175 sold.

Nomura Holdings first reported a position in VIVO in Q3 2013 and held it in 11 quarters. The position peaked at $842K in Q3 2017. 177 funds tracked by Wall St. Rank hold VIVO as of Q2 2018.

Nomura Holdings reported no remaining Meridian Bioscience Inc position as of Q2 2018 after selling out during the quarter.
Nomura Holdings sold 12,268 Meridian Bioscience Inc shares in Q2 2018, an estimated $175.
Nomura Holdings first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 11 quarters.
Nomura Holdings's Meridian Bioscience Inc position peaked at $842K in Q3 2017.
177 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2018.

Based on Nomura Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.